Company
Praxis is a privately held company. Leadership tracked by CEOInsider includes Ross Bowie (CEO).
Current
Praxis Precision Medicines (PRAX) Wins FDA Breakthrough Tag As CNS Pipeline Advances
Is Praxis (PRAX) Trading Bigger Losses for Long-Run CNS Ambition With Its Cash War Chest?
Praxis: Commercial Launch Could Smash Expectations (Video)
RBC Adjusts PT on Praxis Precision Medicines to $462 From $449, Keeps Outperform Speculative Risk Rating
Praxis Precision Medicines Q2 Earnings Call Highlights
Praxis Precision Medicines gains as investors refocus on late-stage CNS pipeline and upcoming FDA catalysts
People: Bengaly Kante brings 15 years of experience to Praxis Profit
Praxis Precision Medicines (NASDAQ: PRAX) holds $1.4B cash, advances NDAs
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
American journalist to discuss crisis facing Cuba during Praxis event
New Tampa insurance carrier taps CEO for ‘phase two’ of expansion
Gothic arch bearings are the secret to this $200 pedal's durability